Children and young adults born completely deaf because of mutations in the OTOF gene have gained measurable hearing after ...

Enrollment expected to complete Q1 2027; topline results anticipated 1H 2028; BLA filing targeted for 2H 2028Phase 1/2 data demonstrated ...

Viral vector release testing requires a battery of analytical methods that, for the most part, did not exist a decade ago, and the regulatory bar rises with every new gene therapy approval. For ...

There is an urgency for improved viral vector technology to meet the needs of the wide array of gene therapies that are in early-stage development. Conventional adeno-associated viruses (AAVs) are ...

Skylark Bio (“Skylark”), a clinical-stage biotechnology company developing targeted genetic medicines for hearing loss, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and ...

When viruses travel through the air in tiny droplets, they can quickly start to dry out. Yet many viruses remain infectious ...

In his decades-long career in tech journalism, Dennis has written about nearly every type of hardware and software. He was a founding editor of Ziff Davis’ Computer Select in the 1990s, senior ...

Ever since humans began building, they’ve been building up. Throughout the millennia, our constructions have reached higher and higher into the sky, spurred by various motivations: religion, democracy ...